REFERENCES
- Gurney J G, Severson R K, Davis S, Robison L L. Incidence of cancer in children in the United States: Sex-, race- and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186–2195, [PUBMED], [INFOTRIEVE], [CSA]
- Gurney J G, Ross J A, Wall D A, et al. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol. 1997; 19: 428–432, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reaman G H, Bleyer A. Infants and adolescents with cancer: special considerations. Principles and Practice of Pediatric Oncology, 4 ed, P A Pizzo, D G Poplack. Lippincott Williams & Wilkins, Philadelphia 2002; 409–427
- Birch J M, Blair V. The epidemiology of infant cancers. Br J Cancer 1992; 66: S2–S4, [CSA]
- Kenney L B, Miller B A, Gloeckler Ries L A, et al. Increased incidence of cancer in infants in the U.S.: 1980–1990. Cancer. 1998; 82: 1396–1400, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McWhirter W R, Dobson C, Ring I. Childhood cancer incidence in Australia, 1982–1991. Int J Cancer 1996; 65: 34–38, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- International Incidence of Childhood Cancer, D M Parkin, E Kramárová, G J Draper, et al. International Agency for Research on Cancer, LyonFrance 1998; vol. 2, Scientific publication No. 114
- Desandes E, Clavel J, Berger C, et al. Cancer incidence among children in France, 1990–1999. Pediatr Blood Cancer. 2004; 43: 749–757, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pui C H, Kane J R, Crist W M. Biology and treatment of infant leukemias. Leukemia 1995; 9: 762–769, [PUBMED], [INFOTRIEVE], [CSA]
- Biondi A, Cimino G, Pieters R, Pui C H. Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24–33, [PUBMED], [INFOTRIEVE], [CSA]
- International Classification of Disease for Oncology, ed. 2, C Percy, V Van Holten, C Muir. World Health Organization, Geneva 1992
- Fu J F, Liang D C, Yang C P, et al. Molecular analysis of t(X;11)(q24;q23) in an infant with AML-M4. Genes Chromosomes Cancer. 2003; 38: 253–259, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Parkes S E, Muir B DR, Southern L, et al. Neonatal tumours: a thirty-year population-based study. Med Pediatr Oncol. 1994; 22: 309–317, [PUBMED], [INFOTRIEVE], [CSA]
- Campbell A N, Chan H SL, O'Brien A, et al. Malignant tumours in the neonate. Arch Dis Child. 1987; 62: 19–23, [PUBMED], [INFOTRIEVE], [CSA]
- Crom D B, Wilimas J A, Green A A, et al. Malignancy in the neonate. Med Pediatr Oncol. 1989; 17: 101–104, [PUBMED], [INFOTRIEVE], [CSA]
- Isaacs H. Congenital and neonatal malignant tumors: a 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol. 1987; 9: 121–129, [PUBMED], [INFOTRIEVE], [CSA]
- Vormoor J, Ritter J, Creutzig U, et al. Acute myelogenous leukaemia in children under 2 years: experiences of the West German AML studies BFM-78, -83 and -87. Br J Cancer 1992; 66: S63–S67, [CSA]
- Dördelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymophoblastic leukemia. Blood. 1999; 94: 1209–1217, [CSA]
- Isaacs H. Fetal and neonatal leukemia. J Pediatr Hematol Oncol. 2003; 25: 348–361, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lion T, Haas O A, Harbott J, et al. The translocation t(1;22)(p13;q13) is a nonramdom marker specifically associated with acute megakaryocytic leukemia in young children. Blood. 1992; 79: 3325–3330, [PUBMED], [INFOTRIEVE], [CSA]
- Bresters D, Reus A CW, Veerman A JP, et al. Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol. 2002; 117: 513–524, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zubizarreta P, Muriel F S, Fernandez Barbieri M A. Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism. Med Pediatr Oncol. 1995; 25: 60–64, [PUBMED], [INFOTRIEVE], [CSA]
- Zipursky A, Brown E J, Christensen H, et al. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999; 19: 157–167, [PUBMED], [INFOTRIEVE], [CSA]
- Brissette M D, Duval-Arnould B J, Gordon B G, Cotelingam J D. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Am J Hematol. 1994; 47: 316–319, [PUBMED], [INFOTRIEVE], [CSA]
- Jiang C J, Liang D C, Tien H F. Neonatal transient leukemoid proliferation followed by acute myeloid leukemia in a phenotypically normal child. Br J Haematol. 1991; 77: 247–248, [PUBMED], [INFOTRIEVE], [CSA]
- Arci M, Biondi A, Pui C H. Juvenile myelomonocytic leukemia. Blood. 1997; 90: 479–488, [CSA]
- Kao L Y, Su W W, Lin Y W. Retinoblastoma in Taiwan: survival and clinical characteristics 1978–2000. Jpn J Ophthalmol. 2002; 46: 577–580, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kramárová E, Stiller C A. The international classification of childhood cancer. Int J Cancer. 1996; 68: 769–765, [CSA]
- Yaris N, Cobanoglu U, Dilber E, et al. Malignant rhabdoid tumor of adrenal gland. Med Pediatr Oncol. 2002; 39: 128–131, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sotelo-Avila C, Gonzales-Cruddi F, deMello D, et al. Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients. Semin Diag Pathol. 1986; 3: 151–163, [CSA]
- Bonnin J M, Bubinstein L J, Palmer N F, Beckwith J B. The association of embryonal tumors originating in the kidney and in the brain: a report of seven cases. Cancer 1984; 54: 2137–2146, [PUBMED], [INFOTRIEVE], [CSA]